Using BNP to Diagnose Heart Failure in Emergency Rooms
Author Information
Author(s): Korenstein Deborah, Wisnivesky Juan P, Wyer Peter, Adler Rhodes, Ponieman Diego, McGinn Thomas
Primary Institution: Mount Sinai School of Medicine, New York, USA
Hypothesis
The study aims to systematically review the accuracy of B-type natriuretic peptide (BNP) in diagnosing heart failure in emergency department patients with acute dyspnea.
Conclusion
BNP has moderate accuracy in detecting heart failure in the emergency department, with specific cutoffs useful for ruling out or diagnosing the condition.
Supporting Evidence
- The pooled sensitivity of BNP at a cutoff of 100-105 pg/ml was 90%, and specificity was 74%.
- At cutoffs between 300 and 400 pg/ml, sensitivity was 81% and specificity was 90%.
- The study included ten studies with a total of 3,344 participants.
Takeaway
Doctors can use a blood test called BNP to help figure out if someone has heart failure when they have trouble breathing. If the BNP level is low, heart failure is unlikely, and if it's high, heart failure is likely.
Methodology
The study conducted a systematic review of literature from MEDLINE, assessing studies that reported the sensitivity and specificity of BNP for diagnosing heart failure in emergency department patients.
Potential Biases
Potential selection and verification bias were present in several studies, affecting the reliability of the results.
Limitations
Many studies had variable quality, possible selection and verification bias, and included patients with obvious medical causes of dyspnea.
Participant Demographics
Participants were primarily older adults, with a mean age ranging from 64 to 80 years, and a gender distribution of 45% to 93% male.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website